Quant Health offers drug simulation, computational biology, clinical data science, respiratory, trial simulation, and oncology services.
QuantHealth has raised $2.0M in total funding. The most recent round was Series A. The last funding was announced in January 2024.
QuantHealth's investors include Pitango VC, Renegade Partners, Nina Capital, Boston Millennia Partners, Accenture Ventures.
QuantHealth is headquartered in Tel Aviv, Israel.
Quant Health offers drug simulation, computational biology, clinical data science, respiratory, trial simulation, and oncology services.
QuantHealth is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"QuantHealth — Funding & Investors." VCBacked, January 8, 2024, https://www.vcbacked.co/company/quanthealth. Accessed July 21, 2026.
VCBacked. (2024). QuantHealth — Funding & Investors. Retrieved July 21, 2026, from https://www.vcbacked.co/company/quanthealth
{{cite web |title=QuantHealth — Funding & Investors |url=https://www.vcbacked.co/company/quanthealth |website=VCBacked |access-date=July 21, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated